4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fukuda Denshi Co., Ltd. (6960) operates in the Medical Devices industry and is headquartered in Tokyo, Japan with about 3,497 employees. Its market capitalization is roughly JPY 327 billion. In the fiscal year ended 2026-03-31, 6960 reported JPY 139.7B in revenue and JPY 18.8B in net income.
Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 139.7B | JPY 139.0B | JPY 140.3B | JPY 134.6B | — |
| Gross Profit | JPY 76.5B | JPY 73.8B | JPY 74.4B | JPY 70.4B | — |
| Operating Income (EBIT) | JPY 26.6B | JPY 25.9B | JPY 26.5B | JPY 24.1B | — |
| Net Income | JPY 18.8B | JPY 18.6B | JPY 18.7B | JPY 17.3B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 5.7B) | (JPY 5.5B) | (JPY 5.5B) | (JPY 5.3B) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 225.4B | JPY 221.3B | JPY 209.1B | JPY 206.9B | — |
| Total Liabilities | JPY 36.6B | JPY 39.7B | JPY 40.1B | JPY 43.9B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6960 viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms